scholarly journals Hearing community voices: public engagement in Australian human embryo research policy, 2005–2007

2008 ◽  
Vol 27 (3) ◽  
pp. 217-232 ◽  
Author(s):  
Rachel A. Ankeny ◽  
Susan Dodds
Author(s):  
Ye NIE

LANGUAGE NOTE | Document text in Chinese; abstract also in English. 人類胚胎研究的“十四天規則”作為一條重要的倫理原則已實施四十餘年,被很多國家立法採納。近年來,隨著胚胎技術的飛速發展,科學家們對“十四天規則”提出了新的挑戰,也是對相關的倫理研究和公共政策的制訂提出的挑戰,即我們該怎樣看待人類胚胎研究的公共政策?Ana S litis等在〈新興人體胚胎研究技術、十四天規則和胚胎的特殊地位〉(馬修斯、洛伊、伊爾蒂斯2021)一文中鼓勵科學家從促進善治的角度來看待人類胚胎和胚狀體的研究政策,但並未深入探討其原因和意義,本文主要從善治的特徵出發通過對人類胚胎研究政策制訂中如何實現的探討而對該文的上述核心觀點進行回應。 In the article “Emerging Human Embryo Research Technologies, the 14-day Rule, and the Special Status of the Embryo,” one of the authors' core aims is to encourage scientists to look at human embryo research policy from the perspective of promoting good governance. Starting with the characteristics of good governance, this paper responds to Iltis et al. by discussing how to realize good governance in the formulation of human embryo research policy.


Author(s):  
Jian TANG

LANGUAGE NOTE | Document text in Chinese; abstract also in English. This article argues that the ISSCR's changes to the 14-day rule should be welcomed. In the future of human embryo research oversight in China, bioethics and public engagement should be fully balanced. This is essential to safeguard the public's trust in science.


2020 ◽  
Vol 20 (4) ◽  
pp. 339-367
Author(s):  
Jeanne M. Snelling

Over the last half-century, significant innovations have occurred in the fields of embryology and human assisted reproduction as a result of human embryo research. This dynamic and ethically complex field is generally subject to extensive regulatory oversight. This article examines New Zealand’s legal framework governing such research. It argues that, despite the core legislative objective of establishing a robust and flexible framework, the current legal regime established under the Human Assisted Reproductive Technology Act 2004 is a classic example of regulatory failure. While not a necessary outcome of the devolved, principles-based regulatory scheme, this failure is primarily due to the perceived lack of authority and independence of the statutory policymaking body established under the Act, as well as the broader regulatory environment in which it operates. It argues that a confluence of problems, including Ministerial overreach as well as a lack of transparency and accountability on the part of decision makers, undermine the legitimacy of the current embryo research policy. This regime not only unjustifiably prevents the conduct of valuable embryo research, but also hinders simple quality improvement practices undertaken in the course of ordinary IVF service provision. This article concludes that, given the significance of embryo research as well as the associated ethical and legal challenges, the issue of embryo research should be remitted back to Parliament to legislate directly as a matter of urgency.


Author(s):  
Lian YU

LANGUAGE NOTE | Document text in Chinese; abstract also in English. It is an inspiring idea that public participation should be the key factor for determining the human embryo research policy. However, public participation is missing from the Chinese government's vision of an ethics regulation system for scientific research. This article argues that to develop human embryo research policy for China and a new regulation system globally, the most important tasks may be to set rules for public participation and to understand the views on human embryo and cell-based embryo research ethics held by different stakeholders and the Chinese public.


2001 ◽  
Vol 31 (1) ◽  
pp. 16 ◽  
Author(s):  
Michael J. Meyer ◽  
Lawrence J. Nelson

Nature ◽  
1983 ◽  
Vol 302 (5903) ◽  
pp. 4-5
Author(s):  
Robert Walgate

Science ◽  
2021 ◽  
Vol 371 (6533) ◽  
pp. 998-1000
Author(s):  
Insoo Hyun ◽  
Annelien L. Bredenoord ◽  
James Briscoe ◽  
Sigal Klipstein ◽  
Tao Tan

Sign in / Sign up

Export Citation Format

Share Document